![Reini Juhani Hurme](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Reini Juhani Hurme
Algemeen Directeur bij Zora Biosciences Oy
Profiel
Reini Juhani Hurme is the founder and is the Chief Executive Officer of Zora Biosciences Oy, which is founded in 2006.
He also held the position of Principal at Leiras Oy and Schering Oy.
Actieve functies van Reini Juhani Hurme
Bedrijven | Functie | Begin |
---|---|---|
Zora Biosciences Oy
![]() Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Algemeen Directeur | 14-12-2006 |
Eerdere bekende functies van Reini Juhani Hurme
Bedrijven | Functie | Einde |
---|---|---|
Schering Oy | Corporate Officer/Principal | - |
Leiras Oy
![]() Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Zora Biosciences Oy
![]() Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Leiras Oy
![]() Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million. | Health Technology |
Schering Oy |